Filing Flows

Filing Flows › Companies › Healthequity › Timeline

Healthequity stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+11.8% to $103.63

Healthequity (HQY) stock rose 12% over the last 252 sessions, to $103.63. On the way it reported 0 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 15 Form 144 notices of planned sales, and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.

HQY: a year of the stock with every disclosure on itHQY: a year of the stock with every disclosure on it$80.68$91.02$101$112◆2026-03-30 · Directors and officers: departures, appointments, pay◆2026-04-06 · Directors and officers: departures, appointments, pay◆2026-05-08 · Directors and officers: departures, appointments, pay▽2026-07-02 · Form 144: Michael Fiore plans to sell $228K▽2026-07-08 · Form 144: Michael Henry Fiore plans to sell $194K▽2026-07-08 · Form 144: Scott Cutler plans to sell $118K▽2026-07-08 · Form 144: Delano Ladd plans to sell $103K▽2026-07-08 · Form 144: James M. Lucania plans to sell $270K▽2026-07-08 · Form 144: Stephen Neeleman plans to sell $105K▽2026-07-09 · Form 144: Michael Gathright plans to sell $211K▽2026-07-10 · Form 144: Michael Fiore plans to sell $223K▽2026-08-25 · Form 144: Adrian Dillon plans to sell $804K◆2026-09-30 · Directors and officers: departures, appointments, pay▽2026-10-06 · Form 144: Michael Gathright plans to sell $60K▽2026-10-06 · Form 144: Michael Fiore plans to sell $185K▽2026-10-06 · Form 144: Scott Cutler plans to sell $112K▽2026-10-06 · Form 144: Delano Ladd plans to sell $98K▽2026-10-06 · Form 144: James Lucania plans to sell $257K▽2026-10-06 · Form 144: Stephen Neeleman plans to sell $100K◆2026-10-09 · Directors and officers: departures, appointments, pay◆8-K event▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Oct 9, 20268-KDirectors and officers: departures, appointments, pay−0.6% (−0.6% vs SPY)−0.6% (+1.4% vs SPY)—
Oct 6, 2026Form 144Form 144: Stephen Neeleman plans to sell $100K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Oct 6, 2026Form 144Form 144: James Lucania plans to sell $257K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Oct 6, 2026Form 144Form 144: Delano Ladd plans to sell $98K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Oct 6, 2026Form 144Form 144: Scott Cutler plans to sell $112K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Oct 6, 2026Form 144Form 144: Michael Fiore plans to sell $185K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Oct 6, 2026Form 144Form 144: Michael Gathright plans to sell $60K−0.6% (−1.1% vs SPY)+0.5% (+0.1% vs SPY)+10.8% (+13.5% vs SPY)
Sep 30, 20268-KDirectors and officers: departures, appointments, pay+1.4% (+1.6% vs SPY)+4.3% (+2.3% vs SPY)+15.0% (+13.9% vs SPY)
Aug 25, 2026Form 144Form 144: Adrian Dillon plans to sell $804K0.0% (−0.3% vs SPY)−8.8% (−9.2% vs SPY)−15.3% (−16.1% vs SPY)
Jul 10, 2026Form 144Form 144: Michael Fiore plans to sell $223K−0.4% (−0.9% vs SPY)+4.0% (+4.1% vs SPY)+9.9% (+7.0% vs SPY)
Jul 9, 2026Form 144Form 144: Michael Gathright plans to sell $211K+0.1% (−0.8% vs SPY)+0.4% (−0.9% vs SPY)+8.8% (+5.7% vs SPY)
Jul 8, 2026Form 144Form 144: Stephen Neeleman plans to sell $105K−2.4% (−2.0% vs SPY)−2.6% (−3.1% vs SPY)+7.4% (+4.5% vs SPY)
Jul 8, 2026Form 144Form 144: James M. Lucania plans to sell $270K−2.4% (−2.0% vs SPY)−2.6% (−3.1% vs SPY)+7.4% (+4.5% vs SPY)
Jul 8, 2026Form 144Form 144: Delano Ladd plans to sell $103K−2.4% (−2.0% vs SPY)−2.6% (−3.1% vs SPY)+7.4% (+4.5% vs SPY)
Jul 8, 2026Form 144Form 144: Scott Cutler plans to sell $118K−2.4% (−2.0% vs SPY)−2.6% (−3.1% vs SPY)+7.4% (+4.5% vs SPY)
Jul 8, 2026Form 144Form 144: Michael Henry Fiore plans to sell $194K−2.4% (−2.0% vs SPY)−2.6% (−3.1% vs SPY)+7.4% (+4.5% vs SPY)
Jul 2, 2026Form 144Form 144: Michael Fiore plans to sell $228K+3.2% (+3.4% vs SPY)+2.7% (+1.9% vs SPY)+8.6% (+8.4% vs SPY)
May 8, 20268-KDirectors and officers: departures, appointments, pay−3.8% (−4.1% vs SPY)−3.2% (−3.4% vs SPY)+5.1% (+5.1% vs SPY)
Apr 6, 20268-KDirectors and officers: departures, appointments, pay−2.9% (−2.9% vs SPY)−4.3% (−8.4% vs SPY)−1.0% (−10.3% vs SPY)
Mar 30, 20268-KDirectors and officers: departures, appointments, pay+2.5% (−0.3% vs SPY)−0.5% (−4.7% vs SPY)0.0% (−11.8% vs SPY)

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Healthequity: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.